A collaboration between Camallergy and OnDosis promises to usher in a new era in food allergy treatment, combining cutting-edge technology with patient-centric care.
Read more
ALK has obtained acceptance from the MHRA to extend the use of specific lot (batch) numbers of Jext® 150 mcg and Jext® 300 mcg auto-injectors, beyond the labelled expiry date by two months.
Read more
Anaphylaxis UK is deeply saddened to learn of the death of Robin Wynne Williams, a 45-year-old construction engineer who tragically died from anaphylaxis due to a severe food allergy. Senior coroner Kate Robertson has ended the inquest into Robin’s death
Read more
Anaphylaxis UK will be taking part in the Big Give’s Christmas Challenge 2023. From midday 28 November to midday 5 December 2023, donations to our Big Give campaign page will be matched by our supporters The Hospital Saturday Fund. Twice the donation, twice the impact.
Read more
New research finds that measuring water loss through the skin during food challenges can predict anaphylaxis before symptoms appear, increasing patient comfort and safety.
Read more
Researches in the US have completed a trial examining the safety and efficacy of sublingual immunotherapy and found it has potential for long lasting effects and is most effective in young children.
Read more
The biopharmaceutical company DBV Technologies is due to begin two safety trials for Viaskin Peanut in two age groups, known as COMFORT Toddlers and COMFORT Children.
Read more
An employee who was sacked after taking five days off work to recover from a near-fatal allergic reaction has successfully sued his employer on the grounds of disability discrimination.
Read more
A community pharmacist in Co Down, Northern Ireland, has been celebrated as a local hero after treating a woman with adrenaline after a bee sting caused an anaphylactic reaction
Read more